ESOPApr 13, 2026, 05:31 PM
Vistagen Grants 75,000 Stock Options to Each of 5 Executives
AI Summary
Vistagen Therapeutics' Compensation Committee approved retention stock option awards for all company employees, including five key executives. Each of the named executives, such as President and CEO Shawn K. Singh and CFO Nick B. Tressler, received options to purchase up to 75,000 shares of common stock. These options, issued at an exercise price of $0.5358 per share, will vest over a two-year period, with 25% vesting every six months, aiming to incentivize and retain key talent.
Key Highlights
- Vistagen granted retention stock options to all employees.
- Five executives, including CEO and CFO, each received options for 75,000 shares.
- Options have an exercise price of $0.5358 per share.
- Options vest over two years, with 25% vesting every six months.
Price Impact
More from VTGN